Germline pathogenic variants (PVs) in a number of genes predispose to melanoma (9–12), but the largest proportion of familial melanoma cases (20%-40%) are due to PVs in the gene CDKN2A (cyclin-dependent kinase inhibitor 2A) (2, 12). Here, CDKN2A is linked to melanoma.